Tyra Biosciences, Inc. (TYRA) Financials

TYRA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 383.4 million 29.7 million
March 31, 2026 412.0 million 24.5 million
Dec. 31, 2025 282.6 million 23.4 million
Sept. 30, 2025 301.9 million 21.3 million

TYRA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -31.1 million 10.2 million
March 31, 2026 -32.7 million 7.8 million
Dec. 31, 2025 -23.7 million 7.6 million
Sept. 30, 2025 -22.4 million 7.6 million

TYRA Net Income

No data available :(

TYRA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 353.9 million - 5.6 million
March 31, 2026 383.5 million 5.2 million 5.7 million
Dec. 31, 2025 256.0 million 5.3 million 5.8 million
Sept. 30, 2025 274.9 million - 5.5 million

TYRA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 66.0 million
March 31, 2026 61.7 million
Dec. 31, 2025 59.6 million
Sept. 30, 2025 59.7 million

TYRA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 66000 39.2 million 9.8 million -
March 31, 2026 88000 33.3 million 8.5 million -
Dec. 31, 2025 57000 28.2 million 8.3 million -
Sept. 30, 2025 39000 25.5 million 7.5 million -

TYRA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 138000
Dec. 31, 2025 - 132000
Sept. 30, 2025 - -

TYRA

Price: $26.22

52 week price:
9.96
40.65

Earnings Per Share: -2.42 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1674

Market Capitalization: 1.5 billion

Links: